Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chih-Lang Lin

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
Clinical and Molecular Hepatology|January 9, 2024
Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry programMing-Ying Lu, Chung-Feng Huang, Chao-Hung Hung, et al.
Infectious Diseases and Therapy|December 30, 2021
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in TaiwanPin-Nan Cheng, Lein-Ray Mo, Chun-Ting Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2021
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)Chung-Feng Huang, Kuo-Chih Tseng, Pin-Nan Cheng, et al.
Viruses|February 26, 2022
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting AntiviralsYen-Chun Chen, Te-Sheng Chang, Chien-Hung Chen, et al.
Digestive Diseases and Sciences|July 4, 2024
Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in TaiwanChin-Wei Chang, Wei-Fan Hsu, Kuo-Chih Tseng, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
Clinical and Molecular Hepatology|January 9, 2024
Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry programMing-Ying Lu, Chung-Feng Huang, Chao-Hung Hung, et al.
Infectious Diseases and Therapy|December 30, 2021
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in TaiwanPin-Nan Cheng, Lein-Ray Mo, Chun-Ting Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2021
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)Chung-Feng Huang, Kuo-Chih Tseng, Pin-Nan Cheng, et al.
Viruses|February 26, 2022
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting AntiviralsYen-Chun Chen, Te-Sheng Chang, Chien-Hung Chen, et al.
Digestive Diseases and Sciences|July 4, 2024
Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in TaiwanChin-Wei Chang, Wei-Fan Hsu, Kuo-Chih Tseng, et al.
Pageof 11